HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lixuan Wei Selected Research

Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))

1/2018Genetic variant repressing ADH1A expression confers susceptibility to esophageal squamous-cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lixuan Wei Research Topics

Disease

12Neoplasms (Cancer)
02/2023 - 11/2015
3Breast Neoplasms (Breast Cancer)
01/2023 - 01/2021
3Alcoholism (Alcohol Abuse)
01/2022 - 01/2021
3Lung Neoplasms (Lung Cancer)
01/2016 - 01/2014
2Prostatic Neoplasms (Prostate Cancer)
01/2022 - 01/2022
2Esophageal Squamous Cell Carcinoma
01/2018 - 11/2017
2Neoplasm Metastasis (Metastasis)
11/2017 - 01/2017
2Carcinogenesis
01/2016 - 10/2015
1Abdominal Pain (Pain, Abdominal)
12/2023
1Dizziness (Lightheadedness)
12/2023
1Fatigue
12/2023
1Primary Headache Disorders
12/2023
1Mood Disorders (Mood Disorder)
11/2022
1Osteoporosis
11/2022
1Immune System Diseases (Immune Disorders)
11/2022
1COVID-19
11/2022
1Major Depressive Disorder (Major Depressive Disorders)
01/2021
1Neuroinflammatory Diseases
01/2021
1Genetic Predisposition to Disease (Genetic Predisposition)
01/2018
1Carcinoma (Carcinomatosis)
01/2017
1Pancreatic Neoplasms (Pancreatic Cancer)
01/2016
1Fibrosarcoma
10/2015
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
01/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
07/2013
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2013
1Lipoma (Lipomata)
07/2013

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
02/2023 - 11/2015
3Proteins (Proteins, Gene)FDA Link
11/2017 - 07/2013
2GlucocorticoidsIBA
11/2022 - 11/2022
2Acamprosate (Campral)FDA Link
01/2022 - 01/2021
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 11/2017
2Messenger RNA (mRNA)IBA
11/2017 - 01/2017
1Estrogen ReceptorsIBA
01/2023
1enzalutamideIBA
01/2023
1Circulating Tumor DNAIBA
01/2023
1ChromatinIBA
01/2023
1RAD140IBA
01/2023
1Therapeutic UsesIBA
01/2023
1Androgen Receptors (Androgen Receptor)IBA
01/2023
1Antiviral Agents (Antivirals)IBA
11/2022
1Poly Adenosine Diphosphate RiboseIBA
01/2022
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2022
1fibroblast growth factor 21IBA
01/2022
1CatecholaminesIBA
01/2022
1abirateroneIBA
01/2022
1Tryptophan (L-Tryptophan)FDA Link
01/2021
1Ethanol (Ethyl Alcohol)IBA
01/2021
1KynurenineIBA
01/2021
1Trastuzumab (Herceptin)FDA Link
01/2021
1Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
01/2021
1Serotonin (5 Hydroxytryptamine)IBA
01/2021
1Alcohol Dehydrogenase (Alcohol Dehydrogenase (NAD+))IBA
01/2018
1Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
01/2017
1ZincIBA
01/2017
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2017
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
01/2017
1Matrix Metalloproteinases (MMPs)IBA
01/2017
1P-2 (P 2)IBA
10/2016
1ORALIT (ORS)IBA
01/2016
1Long Noncoding RNAIBA
01/2016
1Untranslated RNA (Noncoding RNA)IBA
01/2016
1Caspase 3 (Caspase-3)IBA
01/2016
1LuciferasesIBA
01/2016
1MicroRNAs (MicroRNA)IBA
10/2015
1PlatinumIBA
01/2014

Therapy/Procedure

3Therapeutics
01/2023 - 01/2021
3Drug Therapy (Chemotherapy)
11/2022 - 01/2014
1Chinese Traditional Medicine (Traditional Chinese Medicine)
12/2023
1Precision Medicine
02/2023
1Complementary Therapies (Alternative Medicine)
01/2022
1Castration
01/2022
1Subcutaneous Injections
10/2015